Search Within

Pediatric Leukemia

  1. "Paul Meyers"
Formats
  1. Journal Article (75)
  2. Meeting Abstract (26)
Groups
  1. Center for Hematologic Malignancies (101)
  2. Pediatrics, Department of (101)
  3. Sarcoma Service (Pediatrics) (101)
  4. Surgery (64)
  5. Hematologic Malignancies Service (38)
  6. Survivorship Research (38)

More Groups

People
  1. Paul Meyers (101)
  2. Michael La Quaglia (54)
  3. Leonard Wexler (44)
  4. Suzanne Wolden (32)
  5. John Healey (23)
  6. Alexander Chou (17)

More People

Years
  1. 2023 (1)
  2. 2022 (3)
  3. 2021 (2)
  4. 2020 (1)
  5. 2019 (2)
  6. 2018 (2)

More Years

Publications
  1. International Journal of Radiation Oncology, Biology, Physics (14)
  2. Journal of Clinical Oncology (12)
  3. Pediatric Blood and Cancer (12)
  4. Journal of Pediatric Surgery (11)
  5. Cancer (9)
  6. Journal of Pediatric Hematology/Oncology (7)

More Publications

Publishers
  1. American Society of Clinical Oncology (16)
  2. Elsevier Inc. (16)
  3. Wiley Periodicals, Inc (12)
  4. W.B. Saunders Co-Elsevier Inc. (11)
  5. American Association for Cancer Research (9)
  6. Wiley Blackwell (9)

More Publishers

Results (101)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Clinical targeted next-generation panel sequencing reveals MYC amplification is a poor prognostic factor in osteosarcoma
    Journal Article

    Marinoff, A. E.; Spurr, L. F.; Fong, C.; Li, Y. Y.; Forrest, S. J.; Ward, A.; Doan, D.; Corson, L.; Mauguen, A.; Pinto, N.; more...
    JCO Precision Oncology (2023)

    Fulltext@MSK | Save
  • Prospective clinical genomic profiling of Ewing sarcoma: ERF and FGFR1 mutations as recurrent secondary alterations of potential biologic and therapeutic relevance
    Journal Article

    Ogura, K.; Elkrief, A.; Bowman, A. S.; Koche, R. P.; de Stanchina, E.; Benayed, R.; Mauguen, A.; Mattar, M. S.; Khodos, I.; Meyers, P. A.; more...
    JCO Precision Oncology (2022)

    Fulltext@MSK | Save
  • Targeted sequencing of 2,138 bone and soft tissue sarcomas reveals commonly altered pathways, subtype-independent genetic clusters, and potential therapeutic targets
    Meeting Abstract

    Nacev, B. A.; Sanchez-Vega, F.; Smith, S.; Antonescu, C.; Rosenbaum, E.; Shi, H.; Tang, C.; Socci, N.; Rana, S.; Gularte-Merida, R.; more...
    Clinical Cancer Research (2022)

    Fulltext@MSK | Save
  • Clinical sequencing of soft tissue and bone sarcomas delineates diverse genomic landscapes and potential therapeutic targets
    Journal Article

    Nacev, B. A.; Sanchez-Vega, F.; Smith, S. A.; Antonescu, C. R.; Rosenbaum, E.; Shi, H.; Tang, C.; Socci, N. D.; Rana, S.; Zehir, A.; more...
    Nature Communications (2022)

    Fulltext@MSK | Save
  • Comprehensive molecular profiling of desmoplastic small round cell tumor
    Journal Article

    Slotkin, E. K.; Bowman, A. S.; Levine, M. F.; Dela Cruz, F.; Coutinho, D. F.; Sanchez, G. I.; Rosales, N.; Modak, S.; Tap, W. D.; Gounder, M. M.; more...
    Molecular Cancer Research (2021)

    Fulltext@MSK | Save
  • Prospective pan-cancer germline testing using MSK-IMPACT informs clinical translation in 751 patients with pediatric solid tumors
    Journal Article

    Fiala, E. M.; Jayakumaran, G.; Mauguen, A.; Kennedy, J. A.; Bouvier, N.; Kemel, Y.; Fleischut, M. H.; Maio, A.; Salo-Mullen, E. E.; Sheehan, M.; more...
    Nature Cancer (2021)

    Fulltext@MSK | Save
  • Extracellular vesicle and particle biomarkers define multiple human cancers
    Journal Article

    Hoshino, A.; Kim, H. S.; Bojmar, L.; Gyan, K. E.; Cioffi, M.; Hernandez, J.; Zambirinis, C. P.; Rodrigues, G.; Molina, H.; Heissel, S.; more...
    Cell (2020)

    Fulltext@MSK | Save
  • Clinical genomic sequencing of pediatric and adult osteosarcoma reveals distinct molecular subsets with potentially targetable alterations
    Journal Article

    Suehara, Y.; Alex, D.; Bowman, A.; Middha, S.; Zehir, A.; Chakravarty, D.; Wang, L.; Jour, G.; Nafa, K.; Hayashi, T.; more...
    Clinical Cancer Research (2019)

    Fulltext@MSK | Save
  • Preliminary tolerability assessment of naxitamab (humanized anti-GD-2 monoclonal antibody) therapy in a phase 2 osteosarcoma trial
    Meeting Abstract

    Dela Cruz, F.; Chou, A.; Roberts, S.; Mauguen, A.; Bonura, J.; Hilliard, J.; Namuduri, M.; Ortiz, M.; Slotkin, E.; Wexler, L.; more...
    Pediatric Blood and Cancer (2019)

    Fulltext@MSK | Save
  • Spontaneous regression in a patient with infantile fibrosarcoma
    Journal Article

    Farouk Sait, S.; Danzer, E.; Ramirez, D.; LaQuaglia, M. P.; Paul, M.
    Journal of Pediatric Hematology/Oncology (2018)

    Fulltext@MSK | Save